Login / Signup

Durable and controlled depletion of neutrophils in mice.

Gael BoivinJulien FagetPierre-Benoit AnceyAspasia GkastiJulie MussardCamilla EngblomChristina PfirschkeCaroline ContatJustine PascualJessica VazquezNathalie Bendriss-VermareChristophe CauxMarie-Catherine VozeninMikael J PittetMatthias GunzerEtienne Meylan
Published in: Nature communications (2020)
Neutrophils are an essential part of the innate immune system. To study their importance, experimental studies often aim to deplete these cells, generally by injecting anti-Ly6G or anti-Gr1 antibodies. However, these approaches are only partially effective, transient or lack specificity. Here we report that neutrophils remaining after anti-Ly6G treatment are newly derived from the bone marrow, instead of depletion escapees. Mechanistically, newly generated, circulating neutrophils have lower Ly6G membrane expression, and consequently reduced targets for anti-Ly6G-mediated depletion. To overcome this limitation, we develop a double antibody-based depletion strategy that enhances neutrophil elimination by anti-Ly6G treatment. This approach achieves specific, durable and controlled reduction of neutrophils in vivo, and may be suitable for studying neutrophil function in experimental models.
Keyphrases
  • bone marrow
  • poor prognosis
  • induced apoptosis
  • skeletal muscle
  • signaling pathway
  • cell proliferation
  • oxidative stress
  • blood brain barrier
  • brain injury
  • replacement therapy